422 related articles for article (PubMed ID: 35159155)
1. Protective Effects of Curcumin in Cardiovascular Diseases-Impact on Oxidative Stress and Mitochondria.
Cox FF; Misiou A; Vierkant A; Ale-Agha N; Grandoch M; Haendeler J; Altschmied J
Cells; 2022 Jan; 11(3):. PubMed ID: 35159155
[TBL] [Abstract][Full Text] [Related]
2. Curcumin, the golden spice in treating cardiovascular diseases.
Li H; Sureda A; Devkota HP; Pittalà V; Barreca D; Silva AS; Tewari D; Xu S; Nabavi SM
Biotechnol Adv; 2020; 38():107343. PubMed ID: 30716389
[TBL] [Abstract][Full Text] [Related]
3. Curcumin improves hypoxia induced dysfunctions in 3T3-L1 adipocytes by protecting mitochondria and down regulating inflammation.
Priyanka A; Anusree SS; Nisha VM; Raghu KG
Biofactors; 2014; 40(5):513-23. PubMed ID: 25110893
[TBL] [Abstract][Full Text] [Related]
4. Curcumin and cardiovascular diseases: Focus on cellular targets and cascades.
Pourbagher-Shahri AM; Farkhondeh T; Ashrafizadeh M; Talebi M; Samargahndian S
Biomed Pharmacother; 2021 Apr; 136():111214. PubMed ID: 33450488
[TBL] [Abstract][Full Text] [Related]
5. Curcuminoids: Implication for inflammation and oxidative stress in cardiovascular diseases.
Li C; Miao X; Li F; Adhikari BK; Liu Y; Sun J; Zhang R; Cai L; Liu Q; Wang Y
Phytother Res; 2019 May; 33(5):1302-1317. PubMed ID: 30834628
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies.
Zeng Y; Luo Y; Wang L; Zhang K; Peng J; Fan G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834734
[TBL] [Abstract][Full Text] [Related]
7. p53 contributes to cardiovascular diseases via mitochondria dysfunction: A new paradigm.
Wang H; Yu W; Wang Y; Wu R; Dai Y; Deng Y; Wang S; Yuan J; Tan R
Free Radic Biol Med; 2023 Nov; 208():846-858. PubMed ID: 37776918
[TBL] [Abstract][Full Text] [Related]
8. Differential proteomic and oxidative profiles unveil dysfunctional protein import to adipocyte mitochondria in obesity-associated aging and diabetes.
Gómez-Serrano M; Camafeita E; López JA; Rubio MA; Bretón I; García-Consuegra I; García-Santos E; Lago J; Sánchez-Pernaute A; Torres A; Vázquez J; Peral B
Redox Biol; 2017 Apr; 11():415-428. PubMed ID: 28064117
[TBL] [Abstract][Full Text] [Related]
9. A Mitochondrial Approach to Cardiovascular Risk and Disease.
Veloso CD; Belew GD; Ferreira LL; Grilo LF; Jones JG; Portincasa P; Sardão VA; Oliveira PJ
Curr Pharm Des; 2019; 25(29):3175-3194. PubMed ID: 31470786
[TBL] [Abstract][Full Text] [Related]
10. Curcumin decreases oxidative stress in mitochondria isolated from liver and kidneys of high-fat diet-induced obese mice.
Martínez-Morúa A; Soto-Urquieta MG; Franco-Robles E; Zúñiga-Trujillo I; Campos-Cervantes A; Pérez-Vázquez V; Ramírez-Emiliano J
J Asian Nat Prod Res; 2013; 15(8):905-15. PubMed ID: 23782307
[TBL] [Abstract][Full Text] [Related]
11. Review of the Protective Mechanism of Curcumin on Cardiovascular Disease.
Yang C; Zhu Q; Chen Y; Ji K; Li S; Wu Q; Pan Q; Li J
Drug Des Devel Ther; 2024; 18():165-192. PubMed ID: 38312990
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Effects of Curcumin Derivatives against Obesity and Associated Metabolic Complications: A Review of In Vitro and In Vivo Studies.
Moetlediwa MT; Ramashia R; Pheiffer C; Titinchi SJJ; Mazibuko-Mbeje SE; Jack BU
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762669
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor.
Lefranc C; Friederich-Persson M; Palacios-Ramirez R; Nguyen Dinh Cat A
J Endocrinol; 2018 Sep; 238(3):R143-R159. PubMed ID: 29875164
[TBL] [Abstract][Full Text] [Related]
14. Curcumin in inflammatory diseases.
Shehzad A; Rehman G; Lee YS
Biofactors; 2013; 39(1):69-77. PubMed ID: 23281076
[TBL] [Abstract][Full Text] [Related]
15. Curcumin and insulin resistance-Molecular targets and clinical evidences.
Jiménez-Osorio AS; Monroy A; Alavez S
Biofactors; 2016 Nov; 42(6):561-580. PubMed ID: 27325504
[TBL] [Abstract][Full Text] [Related]
16. Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases.
Zhang HA; Kitts DD
Mol Cell Biochem; 2021 Oct; 476(10):3785-3814. PubMed ID: 34106380
[TBL] [Abstract][Full Text] [Related]
17. Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy.
Kim BH; Lee ES; Choi R; Nawaboot J; Lee MY; Lee EY; Kim HS; Chung CH
Yonsei Med J; 2016 May; 57(3):664-73. PubMed ID: 26996567
[TBL] [Abstract][Full Text] [Related]
18. Curcumin attenuates indomethacin-induced oxidative stress and mitochondrial dysfunction.
Sivalingam N; Basivireddy J; Balasubramanian KA; Jacob M
Arch Toxicol; 2008 Jul; 82(7):471-81. PubMed ID: 18060385
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction in metabolic syndrome.
Prasun P
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165838. PubMed ID: 32428560
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential and Recent Advances of Curcumin in the Treatment of Aging-Associated Diseases.
Sundar Dhilip Kumar S; Houreld NN; Abrahamse H
Molecules; 2018 Apr; 23(4):. PubMed ID: 29621160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
